Anti-progestin therapy targets hallmarks of breast cancer risk. Simoes BM, Pedley R, McCloskey CW, Roberts M, et al. Nature 2025 Nov 5. doi: 10.1038/s41586-025-09684.

Read + Share

Amedeo Smart

Independent Medical Education

Simoes BM, Pedley R, McCloskey CW, Roberts M, et al. Anti-progestin therapy targets hallmarks of breast cancer risk. Nature 2025 Nov 5. doi: 10.1038/s41586-025-09684.
PMID: 41193807